Frequently Asked Questions

Questions & Answers

Answers about our technology, quantum platform, industry applications, and how to work with us.

Browse by Topic

Find Your Answer

Filter by category or browse all questions below.

All Technology Industries Company Collaboration

We use neutral alkali or alkaline-earth atoms (e.g. rubidium, strontium) as qubits — controlled via laser cooling, magneto-optical trapping, and coherent optical manipulation. Every atom is physically identical, eliminating fabrication variation between qubits entirely.

Rather than a monolithic chip, we engineer qubits as interconnectable modules linked via quantum networking channels. This modular topology allows the system to grow incrementally — a clear and practical path from early systems to large-scale quantum processors.

Our core atom-trapping and laser-cooling platform operates at TRL 4-5. Key spinoff technologies — quantum magnetometers and gravimeters — are on a roadmap to TRL 6-7 for near-term commercial deployment. We publish technical milestones as we reach them.

Neutral atoms offer naturally identical qubits with no fabrication defects, long coherence times, and straightforward reconfigurability. Modular quantum networking is more tractable with atom-photon interfaces, enabling true scalability beyond what monolithic superconducting chips can currently achieve.

Our near-term roadmap prioritises pharmaceutical drug discovery, materials design, cryptography and PQC/QKD, large-scale supply chain optimisation, and national security applications — domains where even modest quantum advantage creates disproportionate value.

Quantum simulation of molecular dynamics, protein folding energetics, and catalyst reaction pathways offers the potential to reduce drug discovery timelines by years and significantly cut computational costs. Early quantum advantage is expected in specific simulation tasks within 3-5 years.

Yes — our quantum magnetometers are designed for brain imaging (MEG) and cardiac diagnostics (MCG) applications. Unlike SQUID-based systems, they operate without cryogenic cooling, significantly reducing system complexity and cost while achieving comparable or superior sensitivity.

Yes — our co-founder Prof. Dr. Umakant Ropal served as Director of IHub Quantum Technology Foundation (I-Hub QTF), funded by India's National Quantum Mission. Our roadmap closely aligns with national quantum computing and sensing priorities.

We are grateful for funding and institutional support from IISER Pune, Department of Science & Technology (DST), Science and Engineering Research Board (SERB), and the Council of Scientific & Industrial Research (CSIR), alongside National Quantum Mission alignment.

Our research and development base is at IISER Pune — H-Cross Block, Department of Physics, Dr. Homi Bhabha Road, Pashan, Pune 411008, Maharashtra, India. Our CTO is also affiliated with the University of Amsterdam for collaborative quantum research.

We welcome research collaborations, technology licensing agreements, and industry partnerships. Please use our contact form or email us directly. We work with academic institutions, government agencies, and private sector organisations across pharma, defence, and logistics.

Yes — we accept applications from motivated PhD candidates, postdocs, and interns in quantum physics, laser physics, atom optics, and quantum engineering. Please email us your CV and a brief statement of interest.

💬

Still have questions?

Our team is happy to answer any specific questions about our technology, partnership opportunities, or collaboration possibilities.

Send Us a Message